Oral evidence transcript
| Published on: | Friday 22 December 2017 |
|---|---|
| Date: | Tuesday 19 December 2017 |
| Meeting on: | Tuesday 19 December 2017 |
| Part of event segment: | Untitled |
| Document ID: | 156510 |
| Citations: |
|
Committees
Work packages
-
Brexit – medicines, medical devices and substances of human origin inquiry
Wednesday 20 September 2017 - Thursday 31 May 2018
Witnesses
-
Professor Alan Boyd, President of Faculty of Pharmaceutical Medicine, Academy of Medical Royal Colleges, Emma Greenwood, Director of Policy, Cancer Research UK, John Maingay, Director of Policy and Public Affairs, British Heart Foundation, Sir Hugh Taylor, Co-Chair, Brexit Health AllianceHugo Fry, UK General Manager, Sanofi, Warwick Smith, Director General, British Generic Manufacturers Association, Phil Thomson, President, Global Affairs, GlaxoSmithKline, John Wilkinson, Partner, Cooley LLP